Neuraxpharm Group

These Pharma Companies Join Forces To Bring Medical Cannabis Products To Czech & Swiss Markets

Panaxia (TASE: PNAX), a cannabis-focused pharmaceutical company and European specialty pharmaceutical company Neuraxpharm Group announced on Thursday the signing of two addendums to their agreement to expand their collaboration into the Czech and Swiss markets.

Panaxia Confirms First Export Of Medical Cannabis Sublingual Tablets To France

Cannabis-focused pharma company Panaxia Labs Israel (TASE:PNAX) (OTCEM:PXLIF) and a subsidiary of Panaxia Global, together with Neuraxpharm Group announced Monday a first export of medical cannabis sublingual tablets from Israel to France.